{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["5(2)"],"submitter":["Calo NC"],"pubmed_abstract":["<h4>Background</h4>Plastic stents (PS), lumen-apposing metal stents (LAMS) and biflanged metal stents (BFMS) are used for initial drainage of pancreatic walled-off necrosis (WON). There are no strong evidence to support the use of LAMS/BFMS over PS, and prior systematic reviews lack comparative analyses and also lack both trial data and observational studies for WON efficacy outcomes. The aim of this study is to compare the efficacy and adverse events (AEs) in LAMS/BFMS versus PS in patients with pancreatic WON.<h4>Methods</h4>A comprehensive search up to December 1, 2020, was performed. The primary outcome was clinical improvement after drainage. Secondary outcomes included AEs and technical failure. Pooled odds ratios (OR) with 95% confidence intervals (CI) were reported using random eff"],"journal":["Journal of the Canadian Association of Gastroenterology"],"pagination":["68-78"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8972216"],"repository":["biostudies-literature"],"pubmed_title":["Comparative Effectiveness of Lumen-Apposing Metal Stents and Plastic Stents for the Treatment of Pancreatic Walled-Off Necrosis: A Meta-analysis."],"pmcid":["PMC8972216"],"pubmed_authors":["Teshima C","Yaghoobi M","May G","Calo NC","Chen YI","Bishay K","Yuan Y","Mosko J"],"additional_accession":[]},"is_claimable":false,"name":"Comparative Effectiveness of Lumen-Apposing Metal Stents and Plastic Stents for the Treatment of Pancreatic Walled-Off Necrosis: A Meta-analysis.","description":"<h4>Background</h4>Plastic stents (PS), lumen-apposing metal stents (LAMS) and biflanged metal stents (BFMS) are used for initial drainage of pancreatic walled-off necrosis (WON). There are no strong evidence to support the use of LAMS/BFMS over PS, and prior systematic reviews lack comparative analyses and also lack both trial data and observational studies for WON efficacy outcomes. The aim of this study is to compare the efficacy and adverse events (AEs) in LAMS/BFMS versus PS in patients with pancreatic WON.<h4>Methods</h4>A comprehensive search up to December 1, 2020, was performed. The primary outcome was clinical improvement after drainage. Secondary outcomes included AEs and technical failure. Pooled odds ratios (OR) with 95% confidence intervals (CI) were reported using random eff","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Apr","modification":"2025-04-19T00:43:08.521Z","creation":"2025-04-07T11:48:16.125Z"},"accession":"S-EPMC8972216","cross_references":{"pubmed":["35368320"],"doi":["10.1093/jcag/gwab024"]}}